A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder

NCT02951988 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1304

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder, Major

Interventions

DRUG: Rapastinel
DRUG: Placebo-matching Rapastinel

Sponsor

Naurex, Inc, an affiliate of Allergan plc